ENHERTU® Granted Priority Review in the U.S. for Patients with HER2 Low Metastatic Breast Cancer
Based on DESTINY-Breast04 results which showed Daiichi Sankyo and AstraZeneca’s ENHERTU is the first HER2…
Based on DESTINY-Breast04 results which showed Daiichi Sankyo and AstraZeneca’s ENHERTU is the first HER2…
Trend Micro research reveals increase complexity and reduced confidence HONG KONG SAR - Media OutReach…
Donations to 40 NGOs sustains long-term community-building for B40 KUALA LUMPUR, MALAYSIA - Media OutReach…
Albanian Energy Minister Directs State Oil Company to Negotiate Final Terms for Amonicë STEINHAUSEN, SWITZERLAND…
SINGAPORE - Media OutReach - 25 July 2022 - Aspire, the #1 all-in-one finance operating…
Announces online training Program for Tech professionals in India, Southeast Asia and Middle East BENGALURU,…
11 years of providing brokerage services marks an important milestone for OctaFX. For the first…
HONG KONG SAR - Media OutReach - 25 July 2022 - Hong Kong's unique advantages…
SINGAPORE - Media OutReach - 25 July 2022 - Premia TNC (Singapore), a market-leading business…
HONG KONG SAR - Media OutReach - 25 July 2022 - With the idea in…